Palo Alto, CA, United States of America

Sukrit Silas

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Sukrit Silas in Quality Control for Sequencing-Based Assays

Introduction

Sukrit Silas is an accomplished inventor based in Palo Alto, CA. He has made significant contributions to the field of biotechnology, particularly in the area of quality control for sequencing-based assays. His innovative work has the potential to enhance the accuracy and reliability of genetic sequencing processes.

Latest Patents

Sukrit Silas holds a patent for a method and system that involves generating a set of quality control template (QCT) molecules. This patent, titled "Quality control templates ensuring validity of sequencing-based assays," outlines a process that includes determining a set of QCT sequence read clusters based on the QCT molecules. The invention aims to establish sequencing-related parameters, such as contamination and molecule count, which are crucial for both sequencing library preparation and sequencing itself. He has 1 patent to his name.

Career Highlights

Sukrit is currently employed at Billiontoone, Inc., where he continues to develop innovative solutions in the field of genetic sequencing. His work at the company reflects his commitment to advancing biotechnology and improving the accuracy of genetic testing.

Collaborations

Sukrit collaborates with talented individuals such as David Tsao and Oguzhan Atay. These partnerships enhance the innovative environment at Billiontoone, Inc. and contribute to the development of cutting-edge technologies.

Conclusion

Sukrit Silas is a notable inventor whose work in quality control for sequencing-based assays is paving the way for advancements in biotechnology. His contributions are essential for improving the reliability of genetic sequencing, and his ongoing work at Billiontoone, Inc. promises to yield further innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…